Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis

Annals of the Academy of Medicine Singapore

Volumn 37, Issue 5, 2008, Pages 372-376

  Woo, Keng Thye ^a   Lau, Yeow Kok ^a   Chan, Choong Meng ^a   Wong, Kok Seng ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

End stage renal failure; Genotyping; Reciprocal creatinine plots

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LOSARTAN;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHRITIS; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; PROTEINURIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 45249118414     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ruggenenti P, Perna A, Benini R, Bertani T, Zoccali C, Maggiore Q, et al; Investigators of the GISEN Group. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in G FR. J Am Soc Nephrol 1999;10:997-1006.
2. Shahinfar S, Dickson T, Zhang Z, Keane WF, Brenner BM; RENAAL Investigators. Baseline predictors of end-stage renal disease risk in patients with type 2 diabetes and nephropathy: new lessons from the RENAAL Study. Kidney Int 2005;93(Suppl):S48-S51.
3. Suissa S, Hutchison T, Brophy JM, Kezouh A. ACE-inhibitor use and long-term risk of renal failure in diabetes. Kidney Int 2006;69:913-9.
4. Hamming I, Goor H, Navis GJ. ACE inhibitor use and the increased long-term risk of renal failure in diabetes. Kidney Int 2006;70:1377-8.
5. Woo KT, Lau YK, Wong KS, Chiang GS. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int 2000;58:2485-91.
6. Vleming LJ, Van Kooten C, Van Dijik M, Hollander AMJ, Pape E, Westendorp GJ. et al. The D-allele of the ACE gene polymorphism predicts a stronger antiproteinuric response to ACE inhibitors. Nephrology l998;4:143-9.
7. Kirschbaum BB. Analysis of reciprocal creatinine plots in renal failure. Am J Med Sci 1986;291:401-4.
8. Woo KT, Lau YK, Wong KS, Chan CM. ACE inhibitor use and the long-term risk of renal failure in diabetics. Kidney Int 2006;70:1376-7.
9. Hamming I, Navis G, Kocks MJ, van Goor H. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J. Pathol 2006;209:129-39.
10. Woo KT, Lau YK, Choong LHL, Zhao Y, Tan HB, Fook-Chong S, et al. IgA nephropathy: effects of clinical indices, ACEI/ATRA therapy and ACE gene polymorphism on disease progression. Nephrology 2002;7:S 166-S172.
11. Jacobsen PK, Tarnow L, Parving HH. Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy? Kidney Int 2006;69:1293-5.
12. Yong D, Qing WQ, Hua L, Kan JJ, Xi CJ, Jin QQ, Chao SH. Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism and IgA nephropathy: a meta-analysis. Am J Nephrol 2006;26:511-8.
13. Wiwanitkit V. Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy:a meta-analysis. Ren Fail 2006;28:697-9.
14. Ng DP, Tai BC, Koh D, Tan KW, Chia KS. Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 2005;48:1008-16.
15. Seki N, Hashimoto N, Suzuki Y, Yagui K, Saito Y. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy. Diabetes Res Clin Pract 2006;72:135-41.
16. So WY, Ma RC, OzakiR, et al. Angiotensin-convertingenzyme(ACE) inhibition in type 2, diabetic patients - interaction with ACE insertion/deletion polymorphism. Kidney Int 2006;69:1438-43.
17. Han SY, Kwon YJ, Jo SK, Shin JH, Cha DR, Cho WY, et al. ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients. Korean J Intern Med 2000;15:13-8.
18. Hashimoto N, Maeshima Y, Satoh M, Odaware M, Sugiyama H, Kashihara N, et al. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 2004;286:F516-F525.